Open PA-07-101 CFDA 93.837 Discretionary

Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01)

Posted by National Institutes of Health

Opportunity snapshot. This Grants.gov announcement — Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01) — is cataloged under number PA-07-101 and tied to CFDA assistance listing 93.837, posted by National Institutes of Health. Grants.gov currently shows the opportunity as open, first posted on December 1, 2006 and last updated on December 5, 2008. The funding category is Discretionary, delivered as a grant.

Award economics. The award range on file is Varies by applicant. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity is open, but Grants.gov has not published a hard closing date — check the official listing for the current deadline and any posted amendments. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully — federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed — it helps clarify scope and scoring priorities.

Award Range

Varies by applicant

Close Date

Not specified

Multiple Receipt Dates - See Link to Full Announcement for details.

Posted

December 1, 2006

Instrument

Grant

Description

-Purpose. This Funding Opportunity Announcement (FOA) issued by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), solicits grant applications from institutions/organizations that propose to exploit present knowledge of Ca2+ regulatory molecules and the role they play in arrhythmogenesis to develop novel therapeutic targets. Critical components of successful responses to this program announcement are (1) preclinical or early clinical testing of promising new therapeutic strategies to terminate and prevent cardiac arrhythmias in established models of human arrhythmogenic disease, and (2) the feasibility to move positive findings to Phase l or ll clinical trials. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.

Eligibility

00;01;02;04;05;06;07;08;11;12;13;20;22;23;25

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>

Key Dates

Posted December 1, 2006
Close Date Not specified
Archive Date October 2, 2009
Last Updated December 5, 2008

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01)", offered by National Institutes of Health. It is associated with CFDA program 93.837. -Purpose. This Funding Opportunity Announcement (FOA) issued by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), solicits grant applications from institution...
Is this opportunity still open?
Yes, this opportunity is currently open for applications.
How much funding is available?
The award range for this opportunity is Varies by applicant.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainGrants Editorial